Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,403 | -276,126 | -228,302 | -340,141 | -306,620 |
| Depreciation Amortization | 4,811 | 5,621 | 6,677 | 11,114 | 9,160 |
| Accounts receivable | 32,626 | 6,113 | -39,235 | 264 | -1,250 |
| Accounts payable and accrued liabilities | 687 | -3,130 | -9,211 | 9,067 | -815 |
| Other Working Capital | -30,959 | 15,341 | -61,468 | 52,584 | 63,685 |
| Other Operating Activity | 9,521 | 59,204 | 61,109 | 46,590 | 55,081 |
| Operating Cash Flow | $-68,717 | $-192,977 | $-270,430 | $-220,522 | $-180,759 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,870 | 125,064 | 112,384 | 32,838 | -116,215 |
| PPE Investments | -246 | -1,198 | -4,193 | -10,580 | -4,513 |
| Other Investing Activity | 0 | 0 | 94,765 | 0 | 0 |
| Investing Cash Flow | $8,624 | $123,866 | $202,956 | $22,258 | $-120,728 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 30,605 | N/A | N/A |
| Debt Repayment | -892 | -947 | -518 | -254 | -389 |
| Common Stock Issued | 9,578 | 3,064 | 23,812 | 105,459 | 429,649 |
| Other Financing Activity | 50,596 | -107 | -815 | -1,261 | -1,686 |
| Financing Cash Flow | $59,282 | $2,010 | $53,084 | $103,944 | $427,574 |
| Beginning Cash Position | 25,987 | 93,088 | 107,478 | 201,798 | 75,711 |
| End Cash Position | 25,176 | 25,987 | 93,088 | 107,478 | 201,798 |
| Net Cash Flow | $-811 | $-67,101 | $-14,390 | $-94,320 | $126,087 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,717 | -192,977 | -270,430 | -220,522 | -180,759 |
| Capital Expenditure | -246 | -1,223 | -4,193 | -10,580 | -4,513 |
| Free Cash Flow | -68,963 | -194,200 | -274,623 | -231,102 | -185,272 |